GAPDH is a key enzyme in glycolysis that catalyzes the first step of the pathway by converting D-glyceraldehyde 3-phosphate (G3P) into 3-phospho-D-glyceroyl phosphate while glucose consumption is increased in most tumor cells, and glycolysis is therefore up-regulated (Warburg effect). Here, GAPDH is linked to neoplasm.